Sutter Health’s expanded deployment of FloPatch, a wearable Doppler ultrasound device developed by Flosonics Medical, marks a significant innovation in patient-centered critical care. As the first wireless, FDA-cleared ultrasound patch for real-time hemodynamic monitoring, FloPatch empowers clinicians to make data-driven decisions about IV fluid administration, particularly in high-acuity environments like emergency and intensive care units. By eliminating the need for bulky or operator-dependent equipment, the device allows frontline staff to quickly assess a patient’s responsiveness to fluids, enabling more personalized and effective interventions without delay.

This technology arrives at a crucial moment, as fluid overload remains a persistent challenge in sepsis management and other acute care scenarios. Studies indicate that nearly one in three patients with sepsis or septic shock are fluid unresponsive-placing them at greater risk for complications such as pulmonary edema and extended hospital stays. FloPatch addresses this clinical gap by helping providers avoid a “one-size-fits-all” approach to fluid therapy. Through real-time assessment of blood flow, clinicians can reduce the likelihood of overtreatment, potentially lowering the need for mechanical ventilation, shortening ICU stays, and improving overall patient outcomes.